COSENTYX
150mgCOSENTYX150mg
COSENTYX (secukinumab) is an IL-17A inhibitor for psoriasis, psoriatic arthritis, and ankylosing spondylitis.
Key Benefits
- IL-17A targeted therapy
- Rapid skin clearance
- Joint protection
- Convenient dosing schedule
Contact Us for Pricing
Get a written quote against a prescription within 24 hours for COSENTYX 150mg. Our team is available 24/7.
Direct line: +44 7429 917553
Prescription required
We do not proceed without one
Licensed Türkiye channels
İTS serial-traceable by karekod
Delivered in person
Not shipped by courier
Written reply
Quote within 24 hours
About COSENTYX 150mg
COSENTYX (secukinumab) 150mg by Novartis is a human monoclonal antibody that selectively targets interleukin-17A, a key cytokine involved in inflammatory diseases. This biologic provides rapid and sustained improvement in psoriasis with high rates of clear skin, and effectively treats psoriatic arthritis and axial spondyloarthritis. COSENTYX is administered via subcutaneous injection with a convenient dosing schedule after the loading period. We provide genuine COSENTYX from Novartis with proper storage and handling for international distribution.
Common Uses
- Plaque psoriasis
- Psoriatic arthritis
- Ankylosing spondylitis
- Non-radiographic axSpA
Related Rheumatology & Immune Products
Explore more rheumatology & immune medications from our catalog
